Semaglutide & Heart Health: Weight Loss Isn’t the Only Benefit
Beyond Weight Loss: How Semaglutide Signals a Revolution in Cardiometabolic Health Nearly 690 million adults worldwide are obese, a figure projected to double by 2050. But the narrative around obesity treatment is undergoing a seismic shift. The recent SELECT trial, and subsequent analyses, demonstrate that semaglutide – initially hailed as a breakthrough weight-loss drug – … Read more